CYP19A1 and chronic myelogenous leukemia, BCR-ABL1 positive: Expressed specifically in malignant pool in ovarian cancer tumor fluid; overexpressed in aromatase inhibitor resistant estrogen receptor-positive (ER+) breast cancer; upregulated in head and neck cancer cell lines; downregulated in chronic myelogenous leukemia stem cells